GB2264496A - Sizing dna by induced fluorescence - Google Patents
Sizing dna by induced fluorescence Download PDFInfo
- Publication number
- GB2264496A GB2264496A GB9302411A GB9302411A GB2264496A GB 2264496 A GB2264496 A GB 2264496A GB 9302411 A GB9302411 A GB 9302411A GB 9302411 A GB9302411 A GB 9302411A GB 2264496 A GB2264496 A GB 2264496A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dna
- dye
- dna fragments
- fragments
- flow stream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004513 sizing Methods 0.000 title claims description 6
- 239000012634 fragment Substances 0.000 claims abstract description 160
- 239000000975 dye Substances 0.000 claims abstract description 86
- 238000000034 method Methods 0.000 claims abstract description 42
- 239000000523 sample Substances 0.000 claims abstract description 20
- 239000002773 nucleotide Substances 0.000 claims abstract description 19
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 13
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 10
- 238000009396 hybridization Methods 0.000 claims abstract description 8
- 108020004414 DNA Proteins 0.000 claims description 168
- 229960005542 ethidium bromide Drugs 0.000 claims description 12
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims description 12
- 108091008146 restriction endonucleases Proteins 0.000 claims description 12
- 238000012546 transfer Methods 0.000 claims description 12
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 10
- 238000010186 staining Methods 0.000 claims description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
- 239000007850 fluorescent dye Substances 0.000 claims description 8
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 claims description 7
- 230000010287 polarization Effects 0.000 claims description 7
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 4
- XJGFWWJLMVZSIG-UHFFFAOYSA-N 9-aminoacridine Chemical compound C1=CC=C2C(N)=C(C=CC=C3)C3=NC2=C1 XJGFWWJLMVZSIG-UHFFFAOYSA-N 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims description 4
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 claims description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 4
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims description 4
- 229960001441 aminoacridine Drugs 0.000 claims description 4
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 claims description 4
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 claims description 4
- 229960003171 plicamycin Drugs 0.000 claims description 4
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims description 4
- -1 Hoechst Chemical compound 0.000 claims 2
- 238000000684 flow cytometry Methods 0.000 abstract description 10
- 238000009826 distribution Methods 0.000 abstract description 9
- 238000012512 characterization method Methods 0.000 abstract description 2
- 230000005284 excitation Effects 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 239000000203 mixture Substances 0.000 description 6
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 108010053770 Deoxyribonucleases Proteins 0.000 description 4
- 102000016911 Deoxyribonucleases Human genes 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000002875 fluorescence polarization Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 102000001218 Rec A Recombinases Human genes 0.000 description 2
- 108010055016 Rec A Recombinases Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000000093 cytochemical effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003239 environmental mutagen Substances 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method is provided for obtaining DNA fingerprints using high speed detection systems, such as flow cytometry to determine unique characteristics of DNA pieces from a selected sample. In one characterization the DNA piece is fragmented at preselected sites to produce a plurality of DNA fragments. The DNA piece or the resulting DNA fragments are treated with a dye effective to stain stoichiometrically the DNA fragments. The fluorescence from the dye in the stained fragments is then examined to generate an output functionally related to the number of nucleotides in each one of the DNA fragments. The intensity of the fluorescence emissions from each fragment is directly proportional to the fragment length. Additional dyes can be bound to the DNA piece and DNA fragments to provide information additional to length information. Oligonucleotide specific dyes and/or hybridization probes can be bound to the DNA fragments to provide information on oligonucleotide distribution or probe hybridization to DNA fragments of different sizes.
Description
BACKGROUND OF THE INVENTION
This invention relates to DNA analysis and, more particularly, to DNA fragment size distribution analysis and sorting. This invention is the result of a contract with the Department of Energy (Contract No.
W-7405-ENG-36).
The human genome is comprised of some three billion nucleotides forming the 22 pairs of chromosomes plus 2 autosomes, each with continuous DNA pieces of 50-500 million nucleotides. The organization and sequence of DNA forming the human genome contains unique information about the source that provides the DNA. One method for accessing this information is to fragment the DNA at sites with known characteristics and then to analyze the distribution of fragment sizes, i.e., the number of nucleotides in each fragment between each of the sites. Polymorphisms in the genome structure lead to substantial variation in the fragment sizes obtained from fragmentation of DNA pieces and allow one to differentiate one person from another or to form a basis for assessing a person's susceptibility to genetic diseases. Analysis of these polymorphisms is often referred to as DNA fingerprinting.
DNA fingerprinting is an important medical diagnostic tool, with additional applications to forensic identification, medical genetics, monitoring the effects of environmental mutagens, and basic molecular biology research. One form of DNA fingerprinting involves "restriction fragment length polymorphism" (RFLP) where restriction enzymes are used to cut a DNA piece from a specific source into shorter pieces, or fragments, of DNA.
RFLP provides a unique pattern of DNA fragments containing a unique DNA sequence ordered by fragment size (the DNA fingerprint) when a DNA specimen is digested with restriction enzymes. There are many known restriction enzymes and each recognizes a specific DNA sequence of four to twelve base pairs at which it cuts the DNA , resulting in smaller fragments of DNA.
Once the DNA piece has been cut into many fragments, electrophoresis is conventionally used to separate the fragments by size. An electric field is placed across a gel containing the fragments causing the smaller fragments to move faster than the larger ones. Gel electrophoresis is a well known technique and has been used to produce band patterns of DNA fragments that form a fingerprint to identify the individual source of the DNA piece under analysis The band patterns of specific DNA sequences are conventionally visualized by binding radioactive DNA probes to the separated DNA fragments and exposing suitable film to the radioactive labeled fragments. See, e.g., J.I.
Thornton, "DNA Profiling," C & N, pp. 18-30 (November 20, 1989); K. Heine, "DNA on Trial," Outlook 26:4, pp. 8-14 (1989). In one variation, the fragment ends are tagged with a fluorescent dye so that the fragment migration time along a known path length in an electrophoretic gel can be determined by automated fluorescence detection. See, e.g.,
A.V. Carrano, "A High-Resolution, Fluorescence-Based,
Semiautomated Method for DNA Fingerprinting," 4 Genomics, pp. 129-136 (1989).
There are, however, several limitations on the.use of gel electrophoresis, particularly where large fragment sizes and radioactive labeling are involved. In both instances, the electrophoretic separation process takes considerable time to provide resolution for large size fragments. The development of images from radioactive probes is an additional time consuming step and has health hazards and environmental concerns associated with radioactive materials. Additionally, the distribution of fragment sizes is logarithmic so that the separation, i.e., resolution, between large fragments is less than for small fragments. Electrophoresis also requires relatively large amounts of DNA to obtain a recognizable pattern.
It is desirable to provide a DNA fragment size analysis technique that uses only small quantities of DNA (maybe only a single strand), provides size information within a short time, and has a high resolution between fragment sizes. These and other problems of the prior art are addressed by the present invention wherein flow cytometry-based techniques are used to obtain a distribution of DNA fragment sizes from a DNA piece.
Accordingly, it is an object of the present invention to provide rapid determination of DNA fragment sizes.
It is another object of the present invention to obtain a high resolution of DNA fragments, particularly long fragments.
One other object of the present invention is to require only a small DNA sample to provide accurate DNA fragment size fingerprints.
vet another object of the present invention is to enable fragment length detection without the use of radioactive labels.
A further object of the present invention is to use fluorescent intensities to determine the length of DNA fragments.
Still another object of the present invention is to use the sorting capabilities associated with flow cytometry to sort the fragments by size, i.e., length, for further study.
Additional objects, advantages and novel features of the invention will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art upon examination of the following or may be learned by practice of the invention. The objects and advantages of the invention may be realized and attained by means of the instrumentalities and combinations particularly pointed out in the appended claims.
SUMMARY OF THE INVENTION
To achieve the foregoing and other objects, and in accordance with the purposes of the present invention, as embodied and broadly described herein, the method of this invention may comprise the -use of an induced fluorescence to quantitate the length of DNA fragments. A piece of DNA is fragmented at preselected sites to produce a plurality of DNA fragments. All of the DNA fragments are treated with a dye effective to stoichiometrically stain the nucleotides along the DNA fragments. The stained DNA fragments are then fluorescently examined to generate an output functionally related to the number of nucleotides in each one of the DNA fragments. In one output, the intensity of the fluorescence emissions from each fragment is directly proportional to the fragment length.
DETAILED DESCRIPTION OF THE INVENTION
In accordance with the present invention, DNA polymorphisms are characterized, i.e., "fingerprinted," using flow cytometry-based techniques to provide a rapid analysis of DNA fragment sizes obtained by fragmenting a selected DNA piece with one or more enzymes selected to cleave DNA at known sequence sites. One exemplary procedure for sizing is the following:
1. A DNA piece from a selected source is fragmented by enzyme digestion to provide a solution of DNA fragments. The nucleotides comprising the DNA piece may be stained, i.e., labeled, with an appropriate fluorescent dye either before or after the DNA piece is fragmented.
2. The stained DNA fragments are passed through a detection apparatus at a concentration and rate effective to provide only one fragment in the fluorescence excitation volume at any one time.
3. Each stained DNA fragment is excited, e.g., with laser irradiation, in the excitation volume and the resulting fluoresence intensity is measured, wherein the intensity of the induced fluorescence is a measure of the amount of stain on the fragment and concomitant fragment length.
4. The number of fragments at each different intensity provides an analysis of the number of fragments of each length produced from the DNA piece by the selected enzyme or enzymes.
A DNA piece may be first selected from any suitable source, e.g., blood, tissue samples, semen, laboratory research specimens, etc. The DNA piece is then fragmented using an enzyme chosen for a particular application of the analysis. One particularly useful type of enzyme is a restriction endonuclease that recognizes specific sites, i.e., specific nucleotide sequences, and cleaves the DNA piece within the identified sequence. For example, the enzyme Eco RI cuts at the double piece recognition site "'GAATTC"'
"'CTTAAG"' Hundreds of different restriction enzymes and their respective cleavage sites are known. It will be appreciated that identical DNA pieces from a single source might be digested with different enzymes to yield a family of fingerprints.Alternatively, a DNA piece may be digested with multiple enzymes to further particularize the fragment size distribution analysis.
Fragmentation, i.e., digestion, of a DNA piece with a selected enzyme is a well-known process, where the optimum digestion conditions are specified by the enzyme manufacturer. A generic restriction enzyme process for use with 0.2-1 jig of DNA is given by J. Sambrook et al.,
Molecular Cloninq, pp. 5.28-5.33, Cold Spring Harbor
Laboratory Press (1989):
1. Place the DNA solution in a sterile microfuge tube and mix with sufficient water to give a volume of 18 pL.
2. Add 2 pL of an appropriate restriction enzyme digestion buffer and mix by tapping the tube. An exemplary buffer may be formed as follows:
200 mM potassium glutamate
50 mM Tris-acetate (pH 7.5)
20 mM magnesium acetate
100 jig/mL bovine serum albumin (Fraction V; Sigma)
1 mM 8-mercaptoethanol.
3. Add 1-2 units of restriction enzyme and mix by tapping the tube, where 1 unit of enzyme is defined as the amount required to digest 1 pg of DNA to completion in 1 hour in the recommended buffer and at the recommended temperature in a 20-jiL reaction.
4. Incubate the mixture at the appropriate temperature for the required period of time.
5. Stop the reaction by adding 0.5 M EDTA (pH 8.0) to a final concentration of 10 mM.
DNA can be fragmented by a variety of other techniques in addition to restriction enzyme digest:
1. DNase hypersensitivity sites (DNase footprinting). Chromatin digestion by DNase will produce fragments of various lengths due to differences in proteins that bind to the DNA and prevent cutting of the DNA by a
DNase at sites where protein is bound (D.J. Galas et al.,
Nucleic Acids Res., 5:3157 (1987)).
2. RNase cleavage of single-base pair mismatches. A fluorescent RNA probe is synthesized complementary to a normal, or wild type, DNA sequence of interest. This complementary probe is then annealed to the target DNA that is to be analyzed. To determine if a single nucleotide mismatch exists between the fluorescent probe strand and the target DNA strand, the RNA:DNA hybrid is treated with
RNase A. RNase A specifically cleaves single stranded regions of RNA, thus cleaving the single base pair mismatch region in the fluorescent RNA strand of the RNA:DNA hybrid.
(See R.M. Myers et al., Science 230:1242 (1985) and E.F.
Winter et al., Proc. Natl. Acad. Sci. 82:7525 (1985)).
3. RecA-assisted restriction endonuclease cleavage.
Short oligonucleotides coated with RecA protein are annealed to the complementary target DNA sequence. The
DNA:oligonucleotide hybrid is treated with Eco RI methylase enzyme. Eco RI sites that are not protected by the oligonucleotide are methylated while oligonucleotide protected Eco RI sites remain unaffected. Eco RI restriction endonuclease will cleave only at protected sites (i.e., unmethylated). This method has been used to generate fragments > 500,000 base pairs. (L.J. Ferrin,
Science, 254:1494 (1991).
4. DNA fragmentation can also be accomplished by techniques other than enzyme digestion. For example, ultrasonic excitation at different frequencies might be used to produce a family of size distributions. Various chemicals also react with the nucleotides and may be used to fragment DNA pieces.
The DNA fragments must be stained with a fluorescent dye for flow cytometric analysis. A fluorescent dye is selected to bind stoichiometrically to the DNA fragments.
The complex may be formed in different ways, i.e., single stranded DNA, double stranded DNA, specific base pairs, etc. Well known dyes include ethidium bro,ide,acridine orange, propidium iodide, DAPI, HoechsW chromomycin, mithramycin, 9 amino acridine, ethidium bromide heterodyne, asymmetric cyanine dyes, or combinations of these dyes for energy transfer. The selected dye or dyes bind to the oligonucleotides stoichiometrically along the DNA sequence, i.e., the binding sites along the fragments are such that the total number of dye molecules along any length of DNA is proportional to the number of base pairs (bp's) forming the DNA.For example, under the staining protocol set forth below, the number of ethidium bromide molecules bound to a DNA fragment is stoichiometric and can be as high as one-half the number of bp's. See, e.g., C.R. Cantor et al., "Binding of Smaller Molecules to Nucleic Acids," in
Biophysical Chemistry. Part III: The Behavior of Biological Macromolecules, p. 1251, W.H. Freeman and Company, 1980.
One exemplary procedure for staining with ethidium bromide is:
Add DNA sample to a solution containing 1-5 jig of
ethidium bromide per mL of solution and TE 8.0 buffer.
A suitable buffer is available from GIBCO and is 10 mM
Tris-HCL and 1 mM EDTA, pH 8.0. The reaction is
complete in 5-10 minutes at room temperature.
The stained DNA fragments are now analyzed using sensitive fluorescence detection techniques to determine the fluorescence intensity from each fragment passing through a detection region and having a high resolution to distinguish adjacent fragment sizes. Theoretically, while only a single DNA piece is needed to obtain the desired distribution analysis, a typical solution will be formed from many DNA pieces and a relative DNA fragment size distribution is obtained. The DNA fragments will typically range in size from 100 bp to 500,000 bp.
It is well-known how to form a sequential flow stream of particles for use in a flow cytometer or similar sensitive fluorescence detection apparatus. See, e.g.,
U.S. Patent 3,710,933, issued January 16, 1973, to Fulwyler et al. and Flow Cvtometrv and Sorting, 2nd Ed., ed. M.R.
Melamed et al., Wiley-Liss, New York, 1990, incorporated herein by reference. A dilute solution of the DNA fragments is formed to a low concentration effective to provide the fragments spaced apart in the flow stream so that only a single fragment is present in the excitation volume. The solution of DNA fragments is then injected within a laminar sheath flow stream for passage through the detection chamber for laser excitation of one fragment at a time. The flow rates of the sample and the sheath are adjusted to maintain separation between particles and to provide the optimum time for each particle in the excitation source. An optimum time is determined from a consideration of sizing rate, detection sensitivity, and photostability of the dye tags. A suitable excitation source is selected to initiate fluoresce in the dye used to stain the DNA fragments.For example, an argon laser at 488 nm is effective to cause ethidium bromide to fluoresce in a band around 600 nm.
The sensitivity of conventional flow cytometry system is improved by providing a small excitation volume, e.g., 10-20 pm diameter and 100 jim length, with a tightly focused laser beam. See, e.g., J.H. Hahn et al., "Laser-Induced Fluorescence Detection of Rhodamine-6G at 6xlO 15M,'' Appl. Spectrosc. 45:743 (1991), describing a probe volume of 11 pL, incorporated herein by reference.
The small probe volume greatly reduces the amount of background emission, i.e., noise, in the output signal.
The laser excitation may be a pulsed laser with a pulse of e.g., about 70ps full width, with time gating to differentiate between dye emission photons (delayed) and
Raman scattering photons (prompt). See, e.g., E.B. Shera et al., "Detection of Single Fluorescent Molecules," Chem.
Phys. Lett. 174:553 (November 1990), The prompt scattered photons occur within the laser pulse time while the dye emissions decay with a several nanosecond lifetime so that a delayed window is effective for discrimination of fluorescence photons from Raman scatter photons.
Alternatively, the laser may be a cw laser. See, e.g.,
S.A. Soper, "Single-Molecule Detection of Rhodamine-6G in
Ethanolic Solutions Using Continuous Wave Laser
Excitation," Anal. Chem. 63:432 (1991). The number of emitted photons can be increased by increasing the DNA fragment transit time through the laser beam and by selecting a dye and solvent with high photostability for the dye. The number of detected photons (photoelectrons) is also increased by increasing the sensitivity of the detection apparatus. Furthermore, the present invention involves DNA fragments rather than single molecules so that the longer fragment length so that a larger output fluorescence intensity is obtained.
It will also be appreciated that the solution may contain some dye that was not bound to the DNA fragments.
This dye will be excited along with bound dye and the system must discriminate between the fluorescence from the unbound and the bound dye. In one embodiment, a pulsed laser and gated detection technique may be used to provide this discrimination. For example, the excited state lifetimes for the unbound and bound ethidium bromide are 2 ns and 23 ns, respectively. Thus, the detection system can be gated to detect only the fluorescence from the bound ethidium bromide and, hence, provide an output signal functionally related to the length of the DNA fragment.
Alternatively, a dye might be selected that provides different fluorescence or absorption wavelengths in the bound and unbound states. For example, a series of asymmetric cyanine dyes are reported by I.D. Johnson et al., "Asymmetric Cyanine Dyes for Fluorescent Staining and
Quantification of Nucleic Acids," Fluorescence
Spectroscopy, Abstract 1806, FASEB J. 6:A314, No. 1 (January 1992).
Polarized fluorescence emission also provides a means of discriminating bound from unbound dye molecules.
Fluorescence polarization of unbound DNA dyes is < 0.05, whereas the fluorescence polarization of DNA bound fluorochromes can be between 0.20 and 0.30. See, e.g.,
L.S. Cram et al., "Fluorescence Polarization and Pulse
Width Analysis of Chromosomes by a Flow System," J.
Histochem. Cytochem. 27:445, No. 1 (1979); T.M. Jovin, "Fluorescence Polarization and Energy Transfer: Theory and
Application," Flow Cytometry and Sorting, Ed. M.R. Melamed et al., pp. 156, John Wiley & Sons (1979). Discrimination is accomplished by using a polarized excitation source and detecting the emissions through a polarization filter placed in front of a fluorescence detector. The polarization filter is aligned with the polarization direction parallel to the polarization direction of the excitation source.
For continuous cw laser excitation, an energy transfer-type scheme may be used to distinguish bound and unbound dye molecules. If a second dye is also bound to the DNA, the bound first dye molecules used for fragment sizing will be in a close proximity to the second dye molecules so that excitation of the second dye molecules will result in energy transfer from the second dye molecules to the first dye molecules. The unbound first and second dye molecules in the surrounding fluid will not be in proximity effective for energy transfer. Thus, only the bound first dye molecules will fluoresce for fragment length determination when the second dye molecules are excited.
By way of example, the DNA specific dyes Hoechst and chromomycin can transfer energy. When Hoechst dye molecules are excited they can transfer energy to chromomycin molecules within a transfer radius of a few angstroms. This energy transfer pair is used in fluorescent analysis of chromosomes by flow cytometry.
See, e.g., R.G. Langlois et al., "Cytochemical Studies of
Metaphase Chromosomes by Flow Cytometry," Chromosoma 77:229 (1980). Excitation by energy transfer may also be done by exciting the nucleotides at around 260 nm with subsequent energy transfer to the bound dye molecules. See, e.g.,
J.B. LePecq et al., "A Fluorescent Complex between Ethidium
Bromide and Nucleic Acids," J. Mol. Biol. 27:87 (1967).
The flow cytometry-type apparatus also provides a high resolution to distinguish between adjacent fragment lengths. Indeed, the resolution is generally limited by shot noise in the photons arising from the fluorescense emissions and the percent resolution increases as the number of base pairs (bp's) forming the DNA fragments increases.
The percent resolution (R) is determined by the length of the fragment (L), the fraction of the fragment tagged (f), the number of photoelectrons collected per tag (b) (b is typically about 30), and the number of times a fragment is sized (N). The mean intensity is given by . The percent resolution R at a standard deviation of 3o is given by
R(%) = 3*100*N1/2*(L*f*b*)l/2/(L*f*b*), where p = L*f*b; o = jl/2.
For example, consider the case of a fragment 1000 bases long. L=1000, f=0.5 (for e.g., ethidium bromide), b=30.
For N=1, c(=15000, a=122.474, and R=2.45%. The resolution improves as N1/2. For N=1000, o=3.87 and
R=0.0775%. Sizing 10, 100, or even 10000 identical fragments is not a problem. There are many more fragments than 10000 in a typical electrophoresis band. Thus, it can be seen that the resolution can be much better than 1% on a 100,000 bp fragment, whereas a resolution of only 10-20% would be expected for separation of fragments in the 100,000 bp range by gel electrophoresis and the resolution degrades further as fragment length increases.
DNA fingerprinting according to the present invention can also be done very rapidly. A typical DNA fingerprint by electrophoresis has about 50 bands. At 1000 fragments per band, 50 bands would require only about 8.3 minutes to develop a fingerprint at a fragment analysis rate of 100 fragments/second. If only a single band is required for the desired resolution, the analysis time would be only about 1 second. If the desired resolution requires 100 fragments per band, then the 50 band analysis would take only about 50 seconds.
In an adaptation of the present invention, hybridization probes can be bound to the DNA restriction fragments and associated with fragment length sizes.
Hybridization probes are conventionally formed containing a probe dye and hybridized to DNA fragments formed by base pair matching from the DNA piece being investigated.
Excitation of the hybridized DNA fragments could then be designed to excite both the size-measuring dye and the probe dye so that correlation of the fluorescent outputs would associate the probe with various fragment lengths.
In situ probe hybridization to DNA is discussed in Methods in Cell Biology, Vol. 33, Z. Darzynkiewicz et al. Ed.,
Academic Press, Inc. (New York 1990), Chapter 37, "Fluorescence In Situ Hybridization with DNA Probes," pp.
383.
In addition to length determination, it is possible to derive coarse base composition information from the DNA strands. For example, the DNA specific dye Hoechst preferentially binds to AT rich regions in DNA and chromomycin preferentially binds to GC rich regions. By exciting the fluorescence of these two dyes, as is done in bivariate chromosome analysis (see Langlois, supra), the
AT:GC ratios for fragments can be determined. This ratio will provide further fingerprinting information in addition to fragment length. Other binding dyes with different sequence specificities can be used for fragment base characterization. Further, synthesis of a piece of DNA in the presence of fluorescently tagged nucleotide precursors will label the piece of DNA according to its base composition and this information can be subsequently associated with the fragment length fluorescence analysis.
For example, replication of a piece of DNA using three normal nucleotides and one fluorescently tagged C nucleotide would then yield information about the number of
G nucleotides in the original piece since the tagged C nucleotides would bind only to G nucletides.
An additional capability of the system can be provided by using various sorting systems associated with flow cytometers. See, e.g., U.S. Patent 3,710,933, sura, and
Flow Cytometry and Sorting, supra. A sorting capability would enable one or more fragment sizes to be sorted from the flow stream for additional processing or study. If hybridization probes are used, the sorting can separate the hybridized fragments from the flow stream.
Conventional sorting apparatus, as discussed in U.S.
Patent 3,710,933 and in T. Lindmo, "Flow Sorters for
Biological Cells," Flow Cvtometry and Sortina.Second Edition, Ed. M. Melamed et al., pp. 145-169, John Wiley & BR<
Sons (1990), uses the fluorescence output signals discussed above. After the fragments have passed through the excitation volume for generating the output, the hydrodynamic flow stream is broken into droplets by, e.g., ultrasonic vibrations, where each drop contains no more than one fragment. Drops containing DNA fragments that have a selected fluorescence response to an excitation are charged by the application of a high voltage pulse across the drops, which then pass through charged plates that generate an electrostatic field to selectively deflect the charged drops.The charge applied to the selected drops is controlled by circuitry that is responsive to fluorescent emissions from the excitation volume within the flow cytometer, where the charging pulse is activated to produce a deflection of drops containing a material emitting fluorescence at a selected wavelength and intensity.
While the above description has been directed to DNA pieces, the process is equally applicable to RNA strands.
Any reference to DNA in this case should be construed to include RNA. Likewise, the form of signal detected is taught to be fluorescence. However, any form of light emission may be obtained, depending on the specific dye, such that the term fluorescence should be interpreted to include phosphorescence and luminescence. Further, the DNA or RNA being fingerprinted may not necessarily be from humans, since all organisms have a genome that determines their specific characteristics.
The foregoing description of the preferred embodiments of the invention have been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed, and obviously many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application to thereby enable others skilled in the art to best utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the claims appended hereto.
Claims (24)
1. A method for sizing DNA fragments, each containing some number of nucleotides, by induced fluorescence, comprising the steps of:
fragmenting a piece of DNA at preselected sites within said piece of DNA to produce a plurality of DNA fragments;
staining said piece of DNA or said DNA fragments with a first dye effective to stain stoichiometrically said nucleotides; and
fluorescently examining said DNA fragments after staining to generate a fluorescence intensity signal from said first dye that is functionally related to the number of nucleotides in each one of said DNA fragments.
2. A method according to Claim 1, wherein the step of fragmenting said piece of DNA comprises the step of subjecting said piece to a restriction enzyme selected to cleave said piece at a known combination of base pairs.
3. A method according to Claim 1, wherein the step of fragmenting said piece of DNA includes the steps of:
binding a selected DNA sequence to said DNA piece to identify selected sites along said piece; and
cleaving said DNA piece at said selected sites to form said plurality of DNA fragments.
4. A method according to Claim 1, wherein the step of staining said DNA piece or said DNA fragments with a first dye includes the step of adding said DNA piece or said DNA fragments to a solution containing a dye selected from the group consisting of ethidium bromide, acridine orange, propidium iodide, DAPI, Hoechstk chromomycin, mithramycin, 9 amino acridine, and ethidium acridine heterodyne.
5. A method according to Claim 2, wherein the step of staining said DNA piece of said DNA fragments with said first dye includes the step of adding said DNA fragments to a solution containing a dye selected from the group consisting of ethidium bromide, acridine orange, propidium iodide, DAPI, Hoechst, chromomycin, mithramycin, 9 amino acridine, and ethidium acridine heterodyne.
6. A method according to Claim 3, wherein the step of staining said DNA piece or said DNA fragments with said first dye includes the step of adding said DNA fragments to a solution containing a dye selected from the group consisting of ethidium bromide, acridine orange, propidium iodide, DAPI, Hoechst, chromomycin, mithramycin, 9 amino acridine, and ethidium acridine heterodyne.
7. A method according to Claim 1, wherein the step of fluorescently examining said DNA fragments includes the steps of:
forming a flow stream of said DNA fragments serially spaced apart in said flow stream;
illuminating said flow stream with a laser effective to cause said first dye to fluoresce; and
measuring the intensity of the total fluorescence from each one of said fragments of DNA in said flow stream.
8. A method according to Claim 7, wherein said step of measuring said total fluorescence intensity further includes the step of differentiating dye molecules bound to said DNA fragments from unbound dye molecules.
9. A method according to Claim 2, wherein the step of fluorescently examining said DNA fragments includes the steps of:
forming a flow stream of said DNA fragments serially spaced apart in said flow stream;
illuminating said flow stream with a laser effective to cause said first dye to fluoresce; and
measuring the intensity of the total fluorescence from each one of said fragments of DNA in said flow stream.
10. A method according to Claim 9, wherein said step of measuring said total fluorescence intensity further includes the step of differentiating dye molecules bound to said DNA fragments from unbound dye molecules.
11. A method according to Claim 3, wherein the step of fluorescently examining said DNA fragments includes the steps of:
forming a flow stream of said DNA fragments serially spaced apart in said flow stream;
illuminating said flow stream with a laser effective to cause said first dye to fluoresce; and
measuring the intensity of the total fluorescence from each one of said fragments of DNA in said flow stream.
12. A method according to Claim 11, wherein said step of measuring said total fluorescence intensity further includes the step of differentiating dye molecules bound to said DNA fragments from unbound dye molecules.
13. A method according to Claim 4, wherein the step of fluorescently examining said DNA fragments includes the steps of:
forming a flow stream of said DNA fragments serially spaced apart in said flow stream;
illuminating said flow stream with a laser effective to cause said first dye to fluoresce; and
measuring the intensity of the total fluorescence from each one of said fragments of DNA in said flow stream.
14. A method according to Claim 13, wherein said step of measuring said total fluorescence intensity further includes the step of differentiating dye molecules bound to said DNA fragments from unbound dye molecules.
15. A method according to Claim 5, wherein the step of fluorescently examining said DNA fragments includes the steps of:
forming a flow stream of said DNA fragments serially spaced apart in said flow stream;
illuminating said flow stream with a laser effective to cause said first dye to fluoresce; and
measuring the intensity of the total fluorescence from each one of said fragments of DNA in said flow stream.
16. A method according to Claim 15, wherein said step of measuring said total fluorescence intensity further includes the step of differentiating dye molecules bound to said DNA fragments from unbound dye molecules.
17. A method according to Claim 6, wherein the step of fluorescently examining said DNA fragments includes the steps of:
forming a flow stream of said DNA fragments serially spaced apart in said flow stream;
illuminating said flow stream with a laser effective to causesaid first dye to fluoresce; and
measuring the total fluorescence intensity from each one of said fragments of DNA in said flow stream.
18. A method according to Claim 17, wherein said step of detecting said total fluorescence further includes the step of differentiating dye molecules bound to said DNA fragments from unbound dye molecules.
19. A method according to Claim 8, wherein the step of differentiating said dye molecules includes the steps of:
staining said DNA oligonucleotides with a second dye effective for energy transfer to said first dye;
exciting said second dye for energy transfer to said first dye; and
measuring the fluorescence intensity from said first dye to output a signal functionally related to the size of said DNA fragment.
20. A method according to Claim 8, wherein the step of differentiating said dye molecules includes the steps of:
exciting said first dye with a polarized source; and
detecting fluorescence from said first dye through a polarization filter oriented in a polarization direction parallel to the polarization of said polarized source.
21. A method according to Claim 8, wherein the step of differentiating said dye molecules includes the steps of:
setting a first detection window related to the lifetime of fluorescence of dye molecules that are not bound to said DNA fragments;
setting a second detection window after said first detection window and related to the lifetime of fluorescence of dye molecules that are bound to said DNA fragments; and
measuring the intensity of the total fluorescence detected within said second window.
22. A method according to Claim 1, further including the steps of:
forming hybridization probes having a predetermined nucleotide sequence with a fluorescent dye tag;
hybridizing said hybridization probes to said DNA fragments; and
fluorescently examining said fluorescent dye tags to determine the association of said probes with fragment size.
23. A method according to Claim 1, further including the step of sorting said stained DNA fragments as a function of said fluorescence intensity signal.
24. A method according to Claim 1, further including the steps of:
staining said DNA strand or DNA fragments with a third dye that binds to selected oligonucleotides; and
fluorescently examining said DNA fragments for emissions from said third dye to relate said selected oligonucleotide content to fragment size.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84111492A | 1992-02-25 | 1992-02-25 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9302411D0 GB9302411D0 (en) | 1993-03-24 |
GB2264496A true GB2264496A (en) | 1993-09-01 |
GB2264496B GB2264496B (en) | 1995-10-25 |
Family
ID=25284049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9302411A Expired - Fee Related GB2264496B (en) | 1992-02-25 | 1993-02-08 | Sizing of fragments from a nucleic acid sequence |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH067198A (en) |
CA (1) | CA2089423A1 (en) |
FR (1) | FR2687687B1 (en) |
GB (1) | GB2264496B (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221654B1 (en) | 1996-09-25 | 2001-04-24 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
WO2003021272A2 (en) * | 2001-08-22 | 2003-03-13 | Union Biometrica, Inc. | Improved axial pattern analysis utilizing organisms having defined marker patterns |
US6540895B1 (en) | 1997-09-23 | 2003-04-01 | California Institute Of Technology | Microfabricated cell sorter for chemical and biological materials |
US7691333B2 (en) | 2001-11-30 | 2010-04-06 | Fluidigm Corporation | Microfluidic device and methods of using same |
US7749737B2 (en) | 2003-04-03 | 2010-07-06 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US7820427B2 (en) | 2001-11-30 | 2010-10-26 | Fluidigm Corporation | Microfluidic device and methods of using same |
US7833708B2 (en) | 2001-04-06 | 2010-11-16 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
US7867454B2 (en) | 2003-04-03 | 2011-01-11 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US8007746B2 (en) | 2003-04-03 | 2011-08-30 | Fluidigm Corporation | Microfluidic devices and methods of using same |
US8129176B2 (en) | 2000-06-05 | 2012-03-06 | California Institute Of Technology | Integrated active flux microfluidic devices and methods |
US8658418B2 (en) | 2002-04-01 | 2014-02-25 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US8828663B2 (en) | 2005-03-18 | 2014-09-09 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US8871446B2 (en) | 2002-10-02 | 2014-10-28 | California Institute Of Technology | Microfluidic nucleic acid analysis |
EP3184624A1 (en) * | 2015-12-22 | 2017-06-28 | Diagenode S.A. | Frequency optimized devices and methods for microfluidic sonication |
US9714443B2 (en) | 2002-09-25 | 2017-07-25 | California Institute Of Technology | Microfabricated structure having parallel and orthogonal flow channels controlled by row and column multiplexors |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115901581A (en) | 2018-03-30 | 2023-04-04 | Idexx实验室公司 | Laser optical assembly for flow cytometer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989003432A1 (en) * | 1987-10-07 | 1989-04-20 | United States Department Of Energy | Method for rapid base sequencing in dna and rna |
WO1990010718A1 (en) * | 1989-03-10 | 1990-09-20 | Millipore Corporation | Sequencing nucleic acids using chemiluminescent detection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102785A (en) * | 1987-09-28 | 1992-04-07 | E. I. Du Pont De Nemours And Company | Method of gene mapping |
SE8802573D0 (en) * | 1988-07-08 | 1988-07-08 | Wallac Oy | MULTI-LABEL TIME-RESOLVED FLUORESCENCE ANALYSIS OF NUCLEIC ACID SEQUENCES USING LANTHANIDE CHELATES |
US5096554A (en) * | 1989-08-07 | 1992-03-17 | Applied Biosystems, Inc. | Nucleic acid fractionation by counter-migration capillary electrophoresis |
-
1993
- 1993-02-08 GB GB9302411A patent/GB2264496B/en not_active Expired - Fee Related
- 1993-02-12 CA CA 2089423 patent/CA2089423A1/en not_active Abandoned
- 1993-02-24 FR FR9302100A patent/FR2687687B1/en not_active Expired - Fee Related
- 1993-02-25 JP JP5037039A patent/JPH067198A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989003432A1 (en) * | 1987-10-07 | 1989-04-20 | United States Department Of Energy | Method for rapid base sequencing in dna and rna |
WO1990010718A1 (en) * | 1989-03-10 | 1990-09-20 | Millipore Corporation | Sequencing nucleic acids using chemiluminescent detection |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8173001B2 (en) | 1996-09-25 | 2012-05-08 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US6344325B1 (en) | 1996-09-25 | 2002-02-05 | California Institute Of Technology | Methods for analysis and sorting of polynucleotides |
US9383337B2 (en) | 1996-09-25 | 2016-07-05 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US6964736B2 (en) | 1996-09-25 | 2005-11-15 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US8388822B2 (en) | 1996-09-25 | 2013-03-05 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US7670471B2 (en) | 1996-09-25 | 2010-03-02 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US6221654B1 (en) | 1996-09-25 | 2001-04-24 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US6540895B1 (en) | 1997-09-23 | 2003-04-01 | California Institute Of Technology | Microfabricated cell sorter for chemical and biological materials |
US8257666B2 (en) | 2000-06-05 | 2012-09-04 | California Institute Of Technology | Integrated active flux microfluidic devices and methods |
US8129176B2 (en) | 2000-06-05 | 2012-03-06 | California Institute Of Technology | Integrated active flux microfluidic devices and methods |
US9926521B2 (en) | 2000-06-27 | 2018-03-27 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US7833708B2 (en) | 2001-04-06 | 2010-11-16 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
US8936764B2 (en) | 2001-04-06 | 2015-01-20 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
US8486636B2 (en) | 2001-04-06 | 2013-07-16 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
WO2003021272A2 (en) * | 2001-08-22 | 2003-03-13 | Union Biometrica, Inc. | Improved axial pattern analysis utilizing organisms having defined marker patterns |
WO2003021272A3 (en) * | 2001-08-22 | 2007-10-11 | Union Biometrica Inc | Improved axial pattern analysis utilizing organisms having defined marker patterns |
US7837946B2 (en) | 2001-11-30 | 2010-11-23 | Fluidigm Corporation | Microfluidic device and methods of using same |
US7691333B2 (en) | 2001-11-30 | 2010-04-06 | Fluidigm Corporation | Microfluidic device and methods of using same |
US8343442B2 (en) | 2001-11-30 | 2013-01-01 | Fluidigm Corporation | Microfluidic device and methods of using same |
US8163492B2 (en) | 2001-11-30 | 2012-04-24 | Fluidign Corporation | Microfluidic device and methods of using same |
US9643178B2 (en) | 2001-11-30 | 2017-05-09 | Fluidigm Corporation | Microfluidic device with reaction sites configured for blind filling |
US7820427B2 (en) | 2001-11-30 | 2010-10-26 | Fluidigm Corporation | Microfluidic device and methods of using same |
US8658418B2 (en) | 2002-04-01 | 2014-02-25 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US9714443B2 (en) | 2002-09-25 | 2017-07-25 | California Institute Of Technology | Microfabricated structure having parallel and orthogonal flow channels controlled by row and column multiplexors |
US10328428B2 (en) | 2002-10-02 | 2019-06-25 | California Institute Of Technology | Apparatus for preparing cDNA libraries from single cells |
US10940473B2 (en) | 2002-10-02 | 2021-03-09 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US9579650B2 (en) | 2002-10-02 | 2017-02-28 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US8871446B2 (en) | 2002-10-02 | 2014-10-28 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US7867454B2 (en) | 2003-04-03 | 2011-01-11 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US9150913B2 (en) | 2003-04-03 | 2015-10-06 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US8007746B2 (en) | 2003-04-03 | 2011-08-30 | Fluidigm Corporation | Microfluidic devices and methods of using same |
US10131934B2 (en) | 2003-04-03 | 2018-11-20 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US8247178B2 (en) | 2003-04-03 | 2012-08-21 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US7749737B2 (en) | 2003-04-03 | 2010-07-06 | Fluidigm Corporation | Thermal reaction device and method for using the same |
US8828663B2 (en) | 2005-03-18 | 2014-09-09 | Fluidigm Corporation | Thermal reaction device and method for using the same |
EP3184624A1 (en) * | 2015-12-22 | 2017-06-28 | Diagenode S.A. | Frequency optimized devices and methods for microfluidic sonication |
Also Published As
Publication number | Publication date |
---|---|
FR2687687B1 (en) | 1997-05-23 |
JPH067198A (en) | 1994-01-18 |
FR2687687A1 (en) | 1993-08-27 |
CA2089423A1 (en) | 1993-08-26 |
GB2264496B (en) | 1995-10-25 |
GB9302411D0 (en) | 1993-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5558998A (en) | DNA fragment sizing and sorting by laser-induced fluorescence | |
GB2264496A (en) | Sizing dna by induced fluorescence | |
JP3650617B2 (en) | How to characterize polymer molecules and other properties | |
Ambrose et al. | Application of single molecule detection to DNA sequencing and sizing | |
US6509158B1 (en) | Image processing and analysis of individual nucleic acid molecules | |
Keller et al. | Single-molecule fluorescence analysis in solution | |
Fraker et al. | Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer | |
US6610256B2 (en) | Image processing and analysis of individual nucleic acid molecules | |
US6294136B1 (en) | Image processing and analysis of individual nucleic acid molecules | |
Zelenin et al. | 7‐amino‐actinomycin D as a specific fluorophore for DNA content analysis by laser flow cytometry | |
Stöhr et al. | Extended application of flow microfluorometry by means of dual laser excitation | |
FI112504B (en) | Procedure for identifying bacteria | |
JP2005525787A (en) | Detection method of gene haplotype by interaction with probe | |
JP4511636B2 (en) | Method for measuring physical properties of nucleic acids by microscopic imaging | |
WO1998010097A2 (en) | Method and apparatus for single molecule two color fluorescent detection and molecular weight and concentration determination | |
Jett et al. | DNA fragment sizing and sorting by laser-induced fluorescence | |
Ambrose et al. | Imaging biological molecules with single molecule sensitivity using near-field scanning optical microscopy | |
EP1831698B9 (en) | Analytical composition and method | |
Jett et al. | Flow cytometry analysis techniques for high-throughput biodefense research | |
Goodwin et al. | Single molecule nucleic acid analysis by fluorescence flow cytometry | |
Keller | SINGLE MOLECULE NUCLEIC ACID ANALYSIS BY FLUORESCENCE FLOW CYTOMETRY | |
Castro et al. | Single-molecule electrophoresis: applications to biomolecular detection | |
Keller et al. | Analytical Applications | |
Vaschenko | METHODS OF STUDYING SUPRAHELICAL EUCARYOTIC DNA | |
Jett | Flow Cytometry: Analyses for All Sizes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20010208 |